← Back to CEO Rankings
Stéphane Bancel

Stéphane Bancel

Moderna (MRNA)
Healthcare
+113.1%
1-Year Stock Performance
--
2024 Compensation
--
News Sentiment

Latest News

Limited recent coverage. Includes older articles for context.
Bloomberg.com
positive

Moderna Upbeat on New Flu Shot to Help Educate Public About MRNA - Bloomberg.com

Moderna Upbeat on New Flu Shot to Help Educate Public About MRNA  Bloomberg.com...

Jun 25, 2026 Read More →
Global Banking & Finance Review
neutral

Moderna Eyes German Production Amid BioNTech Plant Closures - Global Banking & Finance Review

Moderna Eyes German Production Amid BioNTech Plant Closures  Global Banking & Finance Review...

Jun 17, 2026 Read More →
KWSN
neutral

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO - KWSN

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO  KWSN...

Jun 17, 2026 Read More →
StreetInsider
positive

Moderna names new CCO and expands president's role ahead of product launches - StreetInsider

Moderna names new CCO and expands president's role ahead of product launches  StreetInsider...

Jun 16, 2026 Read More →
IndexBox
neutral

Moderna CEO Stephane Bancel on Pandemic Preparedness and Europe's mRNA Gap in 2026 - News and Statistics - IndexBox

Moderna CEO Stephane Bancel on Pandemic Preparedness and Europe's mRNA Gap in 2026 - News and Statistics  IndexBox...

Jun 15, 2026 Read More →